A solitary fibrous tumor (SFT) is a rare neoplasm of mesenchymal origin that comprises less than 2% of all softtissue tumors. 1 SFT occurs in adults 20 to 70 years old and most frequently in those of about 54 years of age, with no gender predilection. 2 SFT components show a mix of connective tissue, cells, and hypervascular areas that consist of varied sizes of multiple blood vessels. 3 SFT has been related to hypoglycemia as well as the production of insulin-like growth factor, osteoarthropathy, and arthralgia. 4 SFTs can be found in the head (mostly in the orbital area), chest wall, mediastinum, pericardium, retroperitoneum, abdominal cavity, or in rare sites such as the meninges, salivary glands, adrenals, urinary bladder, or testis. 2 Forty percent of SFT cases are found in the subcutaneous layer of tissue. 3 Although an SFT is considered a benign tumor, because of its well-defined soft-tissue composition, 10% to 15% of SFTs recur and/or metastasize. 3 An SFT located in the extremities, especially in the legs, has a high possibility of developing into a malignancy. 3 It is important to use diagnostic medical sonography effectively to determine the characterization of a suspected lesion. 5 The radiologist interpreting the sonogram is expected to provide useful information to the referring physician as well as classify the tumor as benign or malignant. 6 The proper diagnostic approach for either a benign or malignant tumor will determine the proper treatment for the patient.
BACKGROUND: Peripheral arterial disease (PAD) denotes vascular disorder which peripheral artery’s obstruction or constriction is found. PAD with diabetic history is more susceptible to ischemic ulcer than PAD with no diabetic. The presence of Diabetes mellitus (DM) in PAD can speed up 4 times greater risk of developing Critical Limb Ischemia. In our hospital, difficulty performing extremity perfusion assessment is often found because those examinations are not available, so possibility of PAD can be missed. Therefore, optimalization use of Doppler Ultrasound (DUS) is important in our case. AIM: The purpose of our case writing is to give information about substantial parameter of DUS in determine presence of PAD and define the role of percutaneous transluminal angioplasty (PTA) in PAD. The earlier PAD discovered, faster further treatment conducted, especially PTA. CASE REPORT: A 65-year-old female patient with intermittent left calf pain for 7 months who went to internal medicine outpatient has reported. She has history of type 2 DM and significant hyperlipidemia. On physical examination, vital signs revealed normal value. Body mass index was 28 kg/m2. Resting ankle-brachial index (ABI) measurement was 1.14 and 1.12 at the right and left dorsalis pedis, respectively. DUS showed spectral narrow, reversal flow and no clear spectral window in superficial femoral artery. There are clear spectral window, spectral narrow, and reversal flow in poplitea artery. No clear spectral window, no spectral narrow, and no reversal flow in anterior tibia artery. Clear spectral window, reversal flow, and no spectral narrow are appear in posterior tibia artery. Arteriogram of left inferior extremity showed middle part partial stenosis of anterior tibia artery. Dilatation with standard balloon for 1 min was done. After that, no stenosis in same location and she wasn’t feel calf pain again. CONCLUSION: Compared with two other parameters, reversal flow in DUS is most important parameter to establish presence of stenosis. PTA is adequate to give revascularization stenosis in PAD.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.